WELCOME TO FOLIUM EUROPE

Your European Leader In API’s and novel food ingredients

Folium Europe, sells botanical Cannabidiol (CBD) and Tetrahydrocannabinol (THC) as Active Pharmaceutical Ingredients on a commercial scale.

about us

Why folium europe?

Folium Europe is setting the highest standards to continue to bring you a premium product. See how we’ve grown to be Europe’s best established cannabinoid company.

Products

Bulk & White Label CBD Products

Our complete line-up of hemp products are held to the highest industry standards to ensure the reliability of product performance and quality designed into our supply chain.

Botanical Cannabidiol (CBD) as Active Pharmaceutical Ingredient

  • Stability: 2 years at or below 25 degrees Celsius
  • Packaging: Aluminum Pouches (Bulk)
  • MOQ: 1.5 kg;
  • Made upon order

Botanical Tetrahydrocannabinol (THC) as Active Pharmaceutical Ingredient

  • Stability: 1 year at or below 25 degrees Celsius
  • Packaging: Glass syringe 250/500/1000 mg or bulk
  • MOQ 1 kg
  • Made upon order

CBD Consumer Products

  • Bulk ingredients
  • Intake oils
  • Soft gels
  • Cosmetics
  • White label services

Research and development for finished drug formulations

  • Please contact use to discuss possibilities

API's

Botanical cannabinoids as Active Pharmaceutical Ingredients

Folium Europe, sells botanical Cannabidiol (CBD) and Tetrahydrocannabinol (THC) as Active Pharmaceutical Ingredients on a commercial scale. The API’s are exclusively produced for us by EU-GMP/API license holder FeyeCon. Other botanical cannabinoid API’s are in the pipeline. Folium Europe works together with the client when it comes to the supply of a new API’s understanding volumes needs during the clinical development.

Product Pipeline

Cannabidiol (CBD)
Commercialisation
Dronabinol* (THC)
Commercialisation
Tetrahydrocannabinolic acid (THCA)
Implementation
Cannabigerol (CBG)
Development
Cannabidiravin (CBDV)
Development

CBD as Novel Food

Folium Europe B.V.’s independent Novel Food dossier for botanical broad spectrum CBD, including all derived ingredients and white label finished products, is in de validation stage with UK Food Standards Agency (FSA). Awaiting approval to move forward to the authorization stage. This application is performed using our own resources, both financially as well as our extensive knowledge on regulation landscape and quality. In our opinion Europe will move to enforce the Novel Food legislation for CBD as has already been the case with the UK (FSA). In parallel, we are also preparing submission to the European Food Safety Authority (EFSA). In the business of cannabinoids quality will prevail.

We will get in touch with you!

Please contact us for more information or questions.

This website uses cookies to ensure you get the best experience on our website. Learn More